Drug recall · October 31, 2018
Metoprolol Succinate Extended Release Tablets recall
Why: Failed dissolution specifications: Out-of-Specification dissolution test result obtained during routine stability testing.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Metoprolol Succinate Extended Release Tablets, USP 50 mg, 100-count bottle, Rx only, Manufactured by: Actavis Laboratories FL, Inc., Fort Lauderdale, FL 33314, Distributed by: Actavis Pharma, Inc., Parsippany, NJ 07054, NDC 62037-831-01
- Lots / codes
Lot # 1220211M, Exp 02/2019
- Quantity
- 53,451 bottles
- Company
- Teva Pharmaceuticals USA, North Wales, PA
- Distribution
- U.S.A. Nationwide including Puerto Rico.
- Initiated
- October 19, 2018 · Voluntary: Firm initiated
- Classified
- November 1, 2018
- Reported
- October 31, 2018
- Ended
- April 3, 2019
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Metoprolol
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.